Skip to content

Effect of Turmeic in treatment of Vitiligo

Evaluation of local effects of Turmeric drug in improvement of lesions in patients with vitiligo in comparison to placebo

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180910040994N1
Enrollment
30
Registered
2019-08-05
Start date
2018-09-23
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo. Vitiligo

Interventions

Intervention 1: Intervention group: Turmeric cream 5% produced by Seagull Laboratory will be used on the lesions, twice a day, for 4 months. Intervention 2: Control group: Moisturizing cream containin

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 65 Years

Inclusion criteria

Inclusion criteria: Suffering from vitiligo Stability of lesions for at least 3 months Less than 20 percent of skin involvement Having symmetrical lesions

Exclusion criteria

Exclusion criteria: Generalized or progressive vitiligo pregnancy or lactation any history of allergy to Curcumin patients who are resistant to other vitiligo therapies such as immunomodulators drugs , photo-therapy and etc. any malignancy or active skin infections

Design outcomes

Primary

MeasureTime frame
Size of lesions. Timepoint: at baseline and 1,2,3 and 4 months after using the drug. Method of measurement: imagej application.;Notice ability of lesions. Timepoint: at the end of the study. Method of measurement: Vitiligo Noticeability Scale Questionnaire.;Percentage of re-pigmentation. Timepoint: at baseline and 1,2,3 and 4 months after using the drug. Method of measurement: taking photo under wood lamp.

Secondary

MeasureTime frame
Quality of life score in patients with vitiligo. Timepoint: before initiation of treatment and after finishing it. Method of measurement: Vitiligo Quality of Life Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Rajabi

Islamic Azad University

mehdirj@aol.co.uk+98 21 2264 0051

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026